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Introduction 
This report summarises UK quarterly vaccine coverage data for each routine childhood 
vaccination for children who reached their first, second, or fifth birthday during the 
evaluation quarter. Analyses are presented at NHS England local team (April 2018 
configuration) and devolved administration levels only. 
Third quarterly report for 2020/21: main 
points 
Key points from the report include: 
• 12-month UK and country-level coverage for all antigens evaluated at the first
birthday decreased when compared to the previous quarter
• UK DTaP/IPV/Hib/HepB3 coverage decreased by 0.5% to 92.1%, PCV2 by 1.6% to
91.3%, MenB2 by 0.7% to 92.4% and Rotavirus by 0.6% to 90.3%.
• at the country-level, Scotland achieved at least 96% coverage for all antigens at 12
months except rotavirus, in Wales coverage was at least 95% and in Northern Ireland
at least 93%
• in England, 12-month coverage DTaP/IPV/Hib/HepB3 decreased by 0.6% to 91.5%,
PCV2 by 1.8% to 90.6%, Rotavirus by 0.5% to 89.9% and MenB by 0.6% to 91.9%
when compared to the previous quarter
• the introduction of social distancing in response to the COVID-19 pandemic from late
March 2020, when some of this cohort would have been scheduled for completing
doses of these vaccines, may have contributed to these modest decreases
• the larger 1.6% decrease for UK PCV2 coverage and observed across all countries,
is mostly attributable to the changed PCV vaccine schedule from two- to one-dose
for babies born on or after 1 January 2020 and probably underestimates completed
PCV courses.  Although the 12-month cohort evaluated this quarter were all born
before 1 January 2020, and therefore would have been scheduled for 2 doses by the
CHIS/GP systems, children starting their PCV vaccine course late and received their
first dose after 1 January 2020 aged at least 12 weeks, would not need a second
dose
• from next quarter (January to March 2021), only PCV1 coverage estimates will be
used for reporting 12-month PCV coverage estimates
• 24-month UK vaccine coverage estimates for all four vaccines offered on or after the
first birthday decreased 0.1% to 0.4% when compared to the previous quarter
• at country level, Scotland was the only country to achieve 95% for all the vaccines
offered from the first birthday; in Wales coverage exceeded 94% and in Northern
Ireland it exceeded 92%
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• in England, coverage for MMR1, PCV booster and Hib/MenC booster was 90.3%,
between 0.3% and 0.5% lower when compared to the previous quarter. MenB
booster decreased 0.2% to 89.3%
• data for the 24-month cohort presented in this report largely reflects vaccines
administered prior to early 2020, before the COVID-19 pandemic started. However,
children who missed some of their routine immunisations and otherwise may have
caught up by the second birthday, may have been impacted by the lockdown and/or
local restrictions from late March 2020 onwards. This could be a contributing factor
to the observed decreases in coverage for some vaccines in some areas presented
in this quarter
• at 5 years the 95% target was achieved for DTaP/IPV/Hib3 in all UK countries and
for MMR1 and Hib/MenC booster in Scotland, Wales and Northern Ireland.
• in England, MMR1 and HibMenC booster coverage decreased by 0.1% to 94.3%
and to 92.6% respectively
• coverage at 5 years for these vaccines primarily reflects vaccinations delivered 4
years ago
• UK coverage for MMR2 increased 0.1% to 87.5% and the pre-school booster
(DTaP/IPV) decreased 0.1% to 86.5%. In England, coverage remained unchanged
at 86.7% for MMR2 and 85.4% for the pre-school booster
1. Cohort definitions for October to
December 2020
Children who reached their first birthday in the quarter (born October to December 
2019) were scheduled to receive their third combined diphtheria, tetanus, acellular 
pertussis, polio, Haemophilus influenzae type b, hepatitis B vaccine (known as 
DTaP/IPV/Hib/HepB or hexavalent vaccine, second PCV, MenB and rotavirus vaccines 
between February and April 2020 [1]. With the exception of rotavirus vaccine which is 
only offered up to 6 months of age, all other vaccines would have been available to 
children in the current cohort up to the first birthday (October to December 2020). 
This is the last quarterly cohort to be routinely offered 2 PCV doses in the first year of 
life, at 8 and 16 weeks, and future quarterly evaluations of PCV coverage at the first 
birthday will assess infants born on or after 1 January 2020 who will have be offered 
1 PCV dose at 12 weeks only [2] (see Section 3.3). 
Children born to hepatitis B surface antigen (HBsAg) positive mothers who reached 
their first birthday in this quarter should also have received monovalent hepatitis B 
vaccine at birth and 4 weeks of age. 
Children who reached their second birthday in the quarter (born October to December 
2018) were scheduled to receive their third DTaP/IPV/Hib/HepB, second PCV, MenB 
and rotavirus vaccinations between February and April 2019, and their first measles, 
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mumps, and rubella (MMR) vaccination, a booster dose of Hib and MenC (given as a 
combined Hib/MenC vaccine), MenB and PCV vaccines at the same visit from 12 
months of age (from October to December 2019). With the exception of rotavirus 
vaccine which is only offered up to 6 months of age, all other vaccines would have been 
available to children in this cohort up to the second birthday (October to December 
2020). 
Children born to hepatitis B surface antigen (HBsAg) positive mothers, who reached 
their second birthday in this quarter (born October to December 2018), were scheduled 
to receive a third dose monovalent hepatitis B vaccine at 1 year of age, in addition to 3 
doses of DTaP/IPV/Hib/HepB at 8, 12 and 16 weeks. 
Children who reached their fifth birthday in the quarter (born October to December 
2015) were scheduled to receive their third dose DTaP/IPV/Hib and second PCV and 1 
MenC vaccination between February and April 2016. They were also scheduled to 
receive their first MMR, Hib/MenC booster and PCV booster after their first birthday 
between October and December 2016, and their pre-school diphtheria, tetanus, 
acellular pertussis, inactivated polio booster (DTaP/IPV) and second dose MMR from 
January 2019. DTaP/IPV/Hib, first and second doses of MMR, and DTaP/IPV would 
have been available to this cohort up to the fifth birthday (October to December 2020). 
Children born in areas where there is a universal neonatal BCG programme (that is, 
where TB incidence ≥40/100,000) who reach their first birthday in this quarter (born 
October to December 2019) were scheduled to receive BCG at birth.  
Coverage evaluated at the first, second and fifth birthdays, by country and new NHS 
England local teams (configuration as at 1 April 2018) are described in the appendix. 
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2. Participation and data quality
Data was received from all Health Boards (HBs) in Scotland, Northern Ireland and 
Wales. In England, Local Teams (LTs) and Child Health Record Departments (CHRDs) 
provided data for all upper tier local authorities (LAs) and the associated General 
Practices (GP). 
All English data were collected through NHS Digital’s Strategic Data Collection Service 
(SDCS). Individual LA and GP data including numerators, denominators, coverage and 
relevant caveats where applicable are available at: 
https://www.gov.uk/government/statistics/cover-of-vaccination-evaluated-rapidly-cover-
programme-2020-to-2021-quarterly-data. GP level data were censored when individual 
values were less than 5. 
Eight London LAs were not able to provide PCV1, therefore a national figure has not 
been calculated, as this would not be representative. PCV1 coverage for the 143 LAs 
that did provide data is available here. 
Detailed caveats regarding any data quality issues for individual English LA data are 
available at: https://www.gov.uk/government/statistics/cover-of-vaccination-evaluated-
rapidly-cover-programme-2020-to-2021-quarterly-data. 
3. Developments in immunisation data
3.1 NHS Digital Child Health Programme 
The Digital Child Health (DCH) programme was created to support the vision in the 
‘NHS England Healthy Children: Transforming Child Health Information’ strategy, which 
aims to transform child health information services by making these systems 
interoperable, reducing the administrative burden of information recording and sharing. 
Part of this programme includes merging CHIS systems into local hubs that can provide 
COVER data for several LAs in one submission. Since April 2017 four CHIS Hubs are 
providing COVER data for all London boroughs. In England, the number of CHIS 
systems has decreased from over 100 in 2015 to around 60 by mid-2019. As different 
phases of the digital strategy are implemented across the country, it is anticipated that 
there may be further temporary, local, data quality issues associated with transition.  
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3.2 Changes to COVER programme scope and reporting methodology 
The collection of COVER data has transferred from PHE to NHS Digital’s Strategic Data 
Collection Service (SDCS) and merged with the current SDCS practice level vaccine 
coverage collection (formally collected via the Child Immunisation Unify2 data 
collection). 
Data for England collected for this report was collected via SDCS and the analysis and 
reporting of the quarterly COVER report remains with PHE. 
In England, the October to December 2020 quarter is the seventh COVER collection to 
include both LA and GP level coverage extracted from CHISs. Quarterly GP data for the 
current quarter are published alongside the routine LA tables on the PHE website. 
These are experimental data and as such should be viewed with caution. Appropriate 
caveats accompany these data tables. 
3.3 Changes to infant PCV schedule for babies born on or after 1 January 2020 
Following the decision in April 2019 to follow a 1+1 PCV schedule, based on the advice 
of the Joint Committee on Vaccination and Immunisation (JCVI), all infants born on or 
after 1 January 2020 are offered a single dose of PCV13 given alongside the routine 
DTaP/IPV/Hib/HepB and rotavirus immunisations at 12 weeks of age, followed by a 
PCV13 booster at 1 year old (on or after the first birthday). This changed schedule is 
referred to as a 1+1 PCV schedule and has replaced the previous schedule of 2+1 (at 8 
and 16 weeks, and a booster dose given at 1 year old (on or after the first birthday)) [2]. 
To continue accurately monitoring the coverage of PCV at 12 months of age the 
COVER programme has been modified to also collect coverage of the first dose of PCV 
(PCV1). From the first quarter of 2020 to 2021 CHISs should be able to report on PCV1 
and PCV2 coverage at 12 months of age, and on PCV booster (dose given on or after 
the first birthday) at 24 months of age. COVER data for PCV2 will drop to zero as 
cohorts move to the 1+1 schedule (that is, births from 1 January 2020 onwards).  
The revised information standard for the COVER programme was published on 
6 February 2020. Organisations are expected to be compliant from 1 July 2020 to 
provide baseline PCV1 coverage, as well as PCV2 coverage. This is the third quarter 
where organisations in England were expected to provide PCV1 coverage and the last 
where PCV2 is presented as the measure of coverage.   
From the next quarter (January to March 2021) only PCV1 coverage at 12 months will 
be published as all children evaluated will have been offered only 1 PCV dose in the 
first year of life. 
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4. Results
4.1 Coverage at 12 months 
UK coverage for all antigens evaluated at the first birthday decreased when compared 
to the previous quarter (table 1)[3]. DTaP/IPV/Hib/HepB3 coverage decreased by 0.5% 
to 92.1%, PCV2 by 1.6% to 91.3%, MenB2 by 0.7% to 92.4% and Rotavirus by 0.6% to 
90.3%. This cohort were born in October to December 2019 and were first offered their 
DTaP/IPV/Hib/HepB3, PCV2, MenB2 and Rota2 vaccines between February and April 
2020; the first lockdown of the COVID-19 pandemic started in late March 2020 and it is 
possible that the introduction of physical distancing measures may have contributed to 
missed appointments.  
Although the 12-month cohort evaluated this quarter were all born before 1 January 
2020, and therefore would have been scheduled for 2 doses by the CHIS/GP systems, 
children starting their PCV vaccine course late and received their first dose after 1 
January 2020 aged at least 12 weeks, would not need a second dose.  
From next quarter only PCV1 coverage estimates will be used for reporting 12 month 
PCV coverage estimates (see section 3.3 above for details). In England, PCV1 
coverage estimates have been requested since the July to September 2020 quarter and 
in the current quarter data were available for 143 of the 151 LAs (coverage ranged from 
80.1% to 100%). This data is available at Local Authority level here. 
In Scotland at least 96% coverage was achieved for all antigens at 12 months except 
rotavirus. In Wales coverage was at least 95% and in Northern Ireland coverage was at 
least 93% (table 1). In England, 12-month coverage DTaP/IPV/Hib/HepB3 decreased by 
0.6% to 91.5%,  PCV2 by 1.8% to 90.6%, Rotavirus by 0.5% to 89.9% and MenB by 
0.6% to 91.9% when compared to the previous quarter. No English local teams 
achieved at least 95% coverage for DTaP/IPV/Hib/HepB3, PCV2 and MenB2.  
4.2 Coverage at 24 months 
Twenty-four month UK vaccine coverage estimates for all vaccines offered on or after 
the first birthday (MMR1, PCV, Hib/MenC and MenB boosters) decreased when 
compared to the previous quarter. MMR1 and PCV booster decreased 0.3% to 90.9%, 
Hib/MenC booster decreased 0.4% to 90.9% and MenB booster decreased 0.1% to  
90.0%.  
At the country level, Scotland was the only country to achieve 95% for all the vaccines 
offered from the first birthday; in Wales coverage exceeded 94% and in Northern Ireland 
it exceeded 92%. In England, coverage for MMR1, PCV, Hib/MenC boosters was 90.3% 
decreasing between 0.3% and 0.5% compared to the previous quarter. MenB booster 
decreased 0.2% to 89.3%. Ten of 13 local teams achieving at least 90% for all four 
vaccines. 
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UK DTaP/IPV/Hib/HepB3 evaluated at the second birthday increased 0.3% to 94.6% 
this quarter. In Scotland, Northern Ireland and Wales coverage was at least 96%; in 
England coverage increased 0.3% to 94.2% with 8 of 13 local teams achieving 95% 
(table 2)[3]. 
Children who reached their second birthday in the quarter (born October to December 
2018) were scheduled to receive MMR1,and Hib/MenC, MenB and PCV booster 
vaccines at the same visit from 12 months of age (from October to December 2019). 
Therefore data for the 24-month cohort presented in this report largely reflects vaccines 
administered prior to early 2020, before the COVID-19 pandemic started. However, 
children who missed some of their routine immunisations and otherwise may have 
caught up by the second birthday, may have been impacted by the lockdown and/or 
local restrictions from late March 2020 onwards. This could be a contributing factor to 
the observed decreases in coverage for some vaccines in some areas presented in this 
quarter. 
4.3 Coverage at 5 years 
All UK countries continue to exceed the 95% WHO target for DTaP/IPV/Hib3 at 5 years. 
(table 3) [3]. This target was also achieved for MMR1 and Hib/MenC booster in 
Scotland, Wales and Northern Ireland. In England, MMR1 decreased 0.1% to 94.3% 
when compared to the previous quarter and 10 local teams achieved the 95% target. 
HibMenC booster also decreased 0.1% to 92.6%. Coverage at 5 years for these 
vaccines primarily reflects vaccinations delivered four years ago. 
UK coverage for MMR2 increased 0.1% to 87.5% and decreased by 0.1% for the pre-
school booster (DTaP/IPV) to 86.4%. In England, coverage for MMR2 and the pre-
school booster remained unchanged at 86.7% and 85.4% respectively. Pre-school 
booster and MMR2 coverage exceeded 90% in the devolved administrations but only 
four English local teams reached this level for both vaccines (table 3).  
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4.4 Neonatal hepatitis B vaccine coverage in England 
This is the ninth quarter where neonatal HepB vaccine coverage data in England 
evaluates 5 doses of hepatitis B vaccine (2 monovalent and 3 hexavalent doses) in 
infants born to hepatitis B surface antigen (HBsAg) positive mothers, who reached the 
age of 1 year in this quarter (that is, those born between October and December 2019). 
It is the fifth quarter when all 24-month-olds will have been offered 3 monovalent 
vaccines (at birth, 4 weeks and 12 months of age), and 3 doses of hexavalent vaccine 
(at 2, 3 and 4 months). 
National coverage at 12 months for 5 doses of a HepB-containing increased by 3% to 
88% compared to the previous quarter [3]. Coverage of 6 doses of a HepB-containing 
vaccine reported for children who reached 2 years of age in the quarter (those born 
between October and December 2018) increased 2% to 79% compared to the last 
quarter (table 4).  
The quality of neonatal HepB vaccine data is variable and coverage by former local 
teams can be based on small numbers. As such, data should be interpreted with 
caution. Where an area reported no vaccinated children, a check was made to ensure 
that this was zero reporting rather than absence of available data.  
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5. Links for country-specific data
Quarterly England data: https://www.gov.uk/government/statistics/cover-of-vaccination-
evaluated-rapidly-cover-programme-2020-to-2021-quarterly-data 
Annual England data: https://digital.nhs.uk/data-and-information/publications/statistical/nhs-
immunisation-statistics 
Quarterly Northern Ireland: http://www.publichealthagency.org/directorate-public-health/health-
protection/vaccination-coverage  
Scotland: http://www.isdscotland.org/Health-Topics/Child-Health/Immunisation/ 
Wales: http://www.wales.nhs.uk/sites3/page.cfm?orgid=457&pid=54144/  
COVER submission and publication dates: 
https://www.gov.uk/government/publications/vaccine-coverage-statistics-publication-dates 
Information for immunisation practitioners and other health professionals: 
https://www.gov.uk/government/collections/immunisation 
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7. Appendix: Tables
Table 1. Completed UK primary immunisations at 12 months by country and England 
local team: October to December 2020 (July to September 2020) 
Table 2. Completed UK primary immunisations at 24 months by country and NHS 
England local team: October to December 2020 (July to September 2020) 
Table 3. Completed UK primary immunisations and boosters at 5 years by country and 
NHS England local team: October to December 2020 (July to September 2020) 
Table 4. Neonatal hepatitis B coverage at 12 and 24 months in England by NHS 
England Area Team: October to December 2020 (July to September 2020) 
Table 5. BCG vaccine coverage at 12 months in English local authorities with TB 
incidence ≥40 per 100,000 and offering a universal programme: October to December 
2020 (July to September 2020) 
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Table 1. Completed UK primary immunisations at 12 months by country and English Local Teams: October to December 2020 






PCV2% Rota2% MenB2% 
United Kingdom 176 92.1 (92.6) 91.3 (92.9) 90.3 (90.9) 92.4 (93.1) 
Wales 7 95.2 (95.8) 95.2 (96.1) 93.4 (94.0) 95.2 (95.9) 
Northern Ireland 4 93.7 (94.5) 93.5 (94.9) 91.7 (92.5) 94.0 (94.6) 
Scotland 14 96.4 (96.8) 96.1 (97.1) 93.9 (94.2) 96.3 (96.9) 
England 153 91.5 (92.1) 90.6 (92.4) 89.9 (90.4) 91.9 (92.5) 
NHS England Local Teams 
London 33 85.8 (87.7) 83.0 (87.4) 85.2 (86.7) 85.9 (87.8) 
North (Yorkshire & Humber) 15 93.0 (93.4) 92.6 (93.9) 91.1 (91.4) 93.2 (93.8) 
North (Lancashire & Grt. Manchester)1 13 90.3 (92.0) 90.4 (93.1) 88.4 (89.6) 91.7 (93.4) 
North (Cumbria & North East)1 13 95.2 (96.2) 94.8 (96.3) 93.7 (94.6) 95.5 (96.3) 
North (Cheshire & Merseyside) 9 91.2 (90.9) 91.5 (92.2) 89.4 (89.9) 92.2 (92.6) 
Midlands & East (North Midlands) 8 94.1 (95.1) 92.9 (95.3) 92.7 (93.5) 94.4 (95.3) 
Midlands & East (West Midlands) 10 90.2 (87.9) 89.6 (88.7) 87.5 (85.7) 90.8 (89.3) 
Midlands & East (Central Midlands) 10 92.9 (93.0) 93.1 (93.8) 91.8 (91.7) 93.5 (93.7) 
Midlands & East (East) 7 93.9 (94.2) 93.5 (94.6) 91.4 (92.5) 93.8 (94.3) 
South West (South West South) 8 93.9 (94.5) 93.1 (94.6) 91.4 (91.9) 94.3 (94.9) 
South West (South West North) 7 94.4 (94.8)  93.8 (95.1) 92.8 (93.4) 94.5 (94.9) 
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South East (Hampshire, Isle of Wight and 
Thames Valley) 
12 94.5 (94.9) 93.8 (94.1) 92.5 (93.0) 94.4 (95.0) 
South East (Kent, Surrey and Sussex) 6 92.5 (92.5) 91.9 (92.9) 90.8 (90.9) 92.8 (92.8) 
†  Local Authorities / Health Boards.  
1. Currently we are not able to report the 2018 local teams in these areas as Cumbria LA does not map to the new configuration
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Table 2. Completed UK primary immunisations at 24 months by country and NHS England local team: October to December 













United Kingdom 176 94.6 (94.3) 90.9 (91.2) 90.9 (91.3) 90.9 (91.2) 90.0 (90.1) 
Wales 7 97.2 (96.7) 94.9 (94.9) 94.6 (94.6) 94.9 (95.0) 94.5 (94.7) 
Northern Ireland 5 96.0 (95.8) 92.7 (92.3) 92.5 (92.1) 92.3 (91.9) 92.2 (91.8) 
Scotland 14 97.4 (96.8) 95.5 (95.0) 95.4 (95.0) 95.1 (94.7) 95.0 (94.3) 
England 151 94.2 (93.9) 90.3 (90.6) 90.3 (90.8) 90.3 (90.7) 89.3 (89.5) 
NHS England local teams* 
London 33 89.9 (90.0) 81.8 (82.7) 82.5 (83.2) 82.3 (83.1) 80.9 (81.4) 
North (Yorkshire & Humber) 15 95.3 (95.3) 92.3 (93.1) 92.3 (93.1) 92.1 (93.0) 91.3 (92.2) 
North (Lancashire & Grt. Manchester)1 13 94.3 (93.8) 90.8 (91.0) 91.0 (91.6) 91.0 (91.7) 90.0 (90.4) 
North (Cumbria & North East)1 13 96.9 (97.0) 95.8 (95.9) 95.9 (96.0) 95.8 (95.8) 95.3 (95.1) 
North (Cheshire & Merseyside) 9 93.9 (92.7) 90.3 (90.7) 90.2 (90.7) 90.1 (90.5) 89.3 (89.2) 
Midlands & East (North Midlands) 8 95.7 (95.4) 92.0 (92.8) 92.0 (92.9) 92.1 (92.8) 91.2 (91.6) 
Midlands & East (West Midlands) 10 93.6 (93.5) 89.0 (88.8) 89.2 (88.6) 89.2 (88.7) 87.6 (87.2) 
Midlands & East (Central Midlands) 10 93.8 (93.2) 92.0 (91.7) 92.2 (92.1) 92.1 (91.7) 90.4 (89.9) 
Midlands & East (East) 7 95.7 (95.9) 93.2 (94.0) 93.3 (94.1) 93.1 (93.8) 92.8 (93.3) 
South West (South West South) 8 96.2 (95.9) 93.6 (93.4) 93.7 (93.4) 93.6 (93.4) 93.4 (92.8) 
South West (South West North) 7 96.2 (95.8) 93.4 (93.3) 93.4 (93.4) 93.4 (93.2) 92.8 (92.6) 
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South East (Hampshire, Isle of Wight 
and Thames Valley) 12
95.8 (95.9) 94.4 (94.9) 93.2 (94.0) 93.3 (94.0) 93.2 (93.3) 
South East (Kent, Surrey and Sussex) 6 95.4 (94.3) 91.4 (91.8) 91.1 (91.7) 91.1 (91.6) 90.5 (90.7) 
†  Local Authorities / Health Boards. 
1. Currently we are not able to report the April 2018 local teams in these areas as Cumbria LA does not map to that configuration.
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Table 3.  Completed UK primary immunisations and boosters at 5 years by country and NHS England local team: October to 








MMR1% MMR2% DTaP/IPV% Hib/MenC% 
United Kingdom 176 95.6 (95.9) 94.6 (94.8) 87.5 (87.4) 86.4 (86.5) 93.0 (93.2) 
Wales 7 96.7 (96.9) 96.4 (96.6) 92.1 (92.0) 92.7 (93.0) 95.1 (95.2) 
N. Ireland 5 96.8 (97.5) 95.5 (96.6) 90.3 (90.3) 91.0 (90.9) 95.0 (95.9) 
Scotland 14 97.8 (98.0) 96.7 (97.0) 92.8 (92.6) 93.3 (93.2) 96.1 (96.4) 
England 151 95.3 (95.6) 94.3 (94.4) 86.7 (86.7) 85.4 (85.4) 92.6 (92.7) 
English Local Teams 
London 33 91.4 (92.0) 88.8 (89.4) 74.1 (75.1) 71.3 (72.5) 86.5 (87.5) 
North (Yorkshire & Humber) 15 96.5 (96.4) 95.8 (95.6) 90.5 (90.0) 89.6 (89.1) 93.9 (93.3) 
North (Lancashire & Grt. Manchester)1 13 94.4 (95.5) 94.6 (94.5) 87.7 (87.5) 86.1 (86.8) 94.0 (93.7) 
North (Cumbria & North East)1 13 96.9 (97.5) 97.2 (97.5) 92.6 (93.4) 92.5 (92.7) 95.5 (95.4) 
North (Cheshire & Merseyside) 9 96.3 (96.3) 95.1 (95.2) 86.8 (86.7) 85.4 (85.2) 94.5 (94.4) 
Midlands & East (North Midlands) 8 97.3 (97.1) 96.2 (96.1) 89.6 (89.2) 88.7 (88.4) 94.5 (94.3) 
Midlands & East (West Midlands) 10 95.3 (95.3) 94.2 (94.3) 85.4 (83.3) 84.7 (82.5) 92.9 (92.8) 
Midlands & East (Central Midlands) 10  96.4 (96.3) 95.5 (95.7) 89.8 (89.6) 88.4 (88.1) 93.2 (93.0) 
Midlands & East (East) 7 96.8 (96.7) 95.8 (95.9) 91.1 (90.9) 90.8 (90.3) 92.8 (93.0) 
South West (South West South) 10 97.1 (97.0) 96.4 (96.4) 92.0 (92.4) 90.3 (90.6) 95.3 (95.3) 
South West (South West North) 7 96.7 (96.5) 96.1 (96.1) 90.9 (90.4) 89.7 (89.4) 95.6 (95.4) 
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South East (Hampshire, Isle of Wight and 
Thames Valley) 
12 96.4 (96.7) 95.4 (95.7) 91.0 (90.9) 90.3 (90.3) 94.9 (94.8) 
South East (Kent, Surrey and Sussex) 6 94.9 (95.6)  95.0 (95.1) 88.3 (88.4) 86.9 (87.6) 92.6 (93.5) 
†  Local Authorities / Health Boards. 
1. Currently we are not able to report the April 2018 local teams in these areas as Cumbria LA does not map to that configuration.
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Table 4. Neonatal hepatitis B coverage at 12 and 24 months in England by NHS England Local Team: October to December 
2020 (July to September 2020) 
NHS England Local Team3 
LA returns with 
12 month data 
12 month 
denominator 








% Coverage at 24 
months2
London 33 of 33 184 89 (88) 33 of 33 192 76 (76) 
North (Yorkshire & Humber) 15 of 15 46 87 (91) 15 of 15 36 83 (76) 
North (Lancashire & Grt. Manchester)3 13 of 13 27 56 (41) 13 of 13 26 50 (16) 
North (Cumbria & North East)3 12 of 13 8 75 (80) 12 of 13 8 75 (73) 
North (Cheshire & Merseyside) 9 of 9 10 70 (70) 9 of 9 11 36 (50) 
Midlands & East (North Midlands) 8 of 8 18 89 (100) 8 of 8 16 88 (100) 
Midlands & East (West Midlands) 10 of 10 46 96 (89) 10 of 10 59 93 (95) 
Midlands & East (Central Midlands) 10 of 10 49 98 (97) 10 of 10 54 85 (86) 
Midlands & East (East) 7 of 7 27 89 (84) 7 of 7 23 74 (82) 
South West (South West South) 8 of 8 9 89 (86) 8 of 8 15 100 (100) 
South West (South West North) 7 of 7 11 82 (94) 7 of 7 8 100 (100) 
South East (Hampshire, Isle of Wight 
and Thames Valley) 
12 of 12 30 90 (95) 12 of 12 32 88 (95) 
South East (Kent, Surrey and Sussex) 6 of 6 14 100 (64) 6 of 6 25 64 (96) 
England1 150 of 151 479 88 (85) 150 of 151 505 79 (77) 
1. Babies offered 2 monovalent HepB vaccines (at birth and one month) and 3 hexavalent vaccines (at 8, 12 and 16 weeks).
2. Babies offered 3 monovalent vaccines at birth, 4 weeks and 12 months, and 3 doses of hexavalent vaccine (at 8, 12 and 16 weeks).
3. Currently we are not able to report the April 2018 local teams in these areas as Cumbria LA does not map to that configuration.
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Table 5. BCG vaccine coverage at 12 months in English local authorities with TB incidence ≥40 per 100,000 and offering a 
universal programme: October to December 2020 (July to September 2020) 
Upper tier Local 
Authority 
Three-year average 
(2014 to 2016) annual 
TB rate per 100,000 
Number of eligible 
children (1st birthday in 





Newham 69.0 1390 74.3 (84.8) 
Brent 57.8 1168 27.1 (31.3) 
Hounslow 47.5 940 20.1 (20.3) 
Ealing 47.3 1174 41.7 (39.7) 
Redbridge 41.5 1116 72.8 (78.5) 
Note: Slough has a TB incidence of 41.8 per 100,000 but does not have a universal programme. 
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